Mises Wire

Pharmaceutical Prices, Patents, and the FDA

HealthPricesValue and Exchange

08/17/2015Mises Wire
Economist Jeffrey Sachs is complaining that some new drugs cost "too much." But after we sift through all the intellectual property rules, the FDA regs, and the government subsidies, it's impossible to guess what a "correct" price for the drugs might be.
Read More
Shield icon library